Second to market and dismissed as inferior to the competition, Sanofi’s Aubagio seemed destined for lower-tier status. Here’s how it overcame the initial obstacles and, five years later, become a potent market force
Why haven’t biosimilars gained ground in the U.S.?
Two point-of-care companies have received hundreds of millions of dollars in funding. One of them, Outcome Health, is facing allegations about padding data.
Drugmakers turn to social — not TV — to market drugs to women
Still, most experts characterize this year’s newly approved women’s health drugs as modest improvements rather than groundbreaking advances in medicine.
Top 25 women’s health brands, based on U.S. sales in 2016